Evidence Library
Filter by drug, type, year, and open access.
Showing 1–5 of 5 results
- Brexpiprazole for the treatment of co-occurring schizophrenia and substance use disorder: a multisite, randomized, controlled trial — Journal of Clinical Psychiatry (2025)• Drug: brexpiprazolePMID
- Antipsychotic-related prolactin changes: a systematic review and dose-response meta-analysis — CNS Drugs (2025)• Drug: brexpiprazolePMID
- Strategies for switching between oral postsynaptic antidopaminergic antipsychotics in patients with schizophrenia: a systematic review — CNS Drugs (2025)• Drug: brexpiprazolePMID
- Brexpiprazole in schizophrenia and major depressive disorder: evidence review — Clinical Schizophrenia & Related Psychoses (2016)• Drug: brexpiprazolePMID
- Brexpiprazole for acute schizophrenia: 6-week randomized trial — Schizophrenia Research (2015)• Drug: brexpiprazoleDOIPMID